Publication
Molecular picture of cobalamin C/D defects before and after newborn screening era
| dc.contributor.author | Nogueira, C. | |
| dc.contributor.author | Marcão, A. | |
| dc.contributor.author | Rocha, H. | |
| dc.contributor.author | Sousa, C. | |
| dc.contributor.author | Fonseca, H. | |
| dc.contributor.author | Valongo, C. | |
| dc.contributor.author | Vilarinho, L. | |
| dc.date.accessioned | 2017-05-11T15:21:23Z | |
| dc.date.available | 2017-05-11T15:21:23Z | |
| dc.date.issued | 2017-03 | |
| dc.description.abstract | Objective: Birth prevalence of Cobalamin (Cbl) C or D defects in Portugal is an estimated 1:85,000, one of the highest worldwide. We compared the genotype/phenotype of patients identified with CblC or CblD before and after the implementation of expanded newborn screening. Methods: Twenty-five Portuguese CblC/D patients, 14 symptomatic and 11 identified through screening, were diagnosed using gas chromatography or tandem mass spectrometry. Molecular characterization was performed through the study of MMACHC and MMADHC genes. Results: The most common MMACHC mutation, c.271dupA, was present in 100% of MMACHC alleles of all CblC screened patients, in contrast with the 61% identified before expanded newborn screening. All studied cases (except one, who presented a CblD deficiency) presented a CblC defect. More CblC late-onset patients were diagnosed before the introduction of newborn screening than in the post newborn screening era, probably because some early onset patients died without a definitive diagnosis. Conclusion: The molecular data found in this cohort contribute to the improvement of screening and diagnosis of Cbl defects and would enable a confirmatory diagnosis of these patients, reducing the need for complex, costly, laborious, and time-consuming biochemical/enzymatic tests. | pt_PT |
| dc.description.version | info:eu-repo/semantics/publishedVersion | pt_PT |
| dc.identifier.citation | J Med Screen. 2017 Mar;24(1):6-11. doi: 10.1177/0969141316641149. Epub 2016 Jul 7. | pt_PT |
| dc.identifier.doi | doi: 10.1177/0969141316641149 | pt_PT |
| dc.identifier.issn | 0969-1413 | |
| dc.identifier.uri | http://hdl.handle.net/10400.18/4705 | |
| dc.language.iso | eng | pt_PT |
| dc.peerreviewed | yes | pt_PT |
| dc.publisher | SAGE Publications | pt_PT |
| dc.relation.publisherversion | http://journals.sagepub.com/doi/pdf/10.1177/0969141316641149 | pt_PT |
| dc.subject | Expanded Newborn Screening | pt_PT |
| dc.subject | MMACHC | pt_PT |
| dc.subject | MMADHC | pt_PT |
| dc.subject | Vitamin B12 | pt_PT |
| dc.subject | Blood Spots | pt_PT |
| dc.subject | Cobalamin | pt_PT |
| dc.subject | Doenças Genéticas | pt_PT |
| dc.title | Molecular picture of cobalamin C/D defects before and after newborn screening era | pt_PT |
| dc.type | journal article | |
| dspace.entity.type | Publication | |
| oaire.citation.endPage | 11 | pt_PT |
| oaire.citation.issue | 24 | pt_PT |
| oaire.citation.startPage | 6 | pt_PT |
| oaire.citation.title | Journal of Medical Screening | pt_PT |
| oaire.citation.volume | 1 | pt_PT |
| rcaap.rights | embargoedAccess | pt_PT |
| rcaap.type | article | pt_PT |
